NEW #EHRA2024 Late-Breaking Interview 💫Dr Boris Schmidt discusses the ASTRO trial on ablation strategies for repeat procedures in patients with recurrent AF.

📽️👉 ow.ly/PZ3550RjZcF

#EPeeps #CardioTwitter

NEW #EHRA24 Interview 💫💭Dr Luigi Di Biase highlights 3 late-breaking trials that will impact EP practice.

📽️👉 ow.ly/9wGi50RjY9c

Trials covered:
✅'Single-Shot' PFA Catheter for #PVI
✅ASTRO AF
✅Style AF

#EPeeps #CardioTwitter

📚 Discover new content on the latest predictors for Pulmonary Embolism treatment selection on our PE learning hub! 🔗 ow.ly/YZ6Y50RjPGW

Prof Sripal Bangalore, Dr Catalin Toma, MD and Prof Felix discuss the #FLASH registry, the need for more evidence in the #PE

Excited to moderate a webinar on POTS based on our review article published last year! Excellent speakers in store and an opportunity for Q&A. Alexis Cutchins, MD Radcliffe Cardiology S Blitshteyn MD, FAAN, Dysautonomia Clinic Emory Women's Heart

Did you miss out on the TRI-HERO launch webinar?

The full webinar is now available to watch on-demand here - tinyurl.com/33y8my6t

James Nolan, Ivo Bernat, Alison Dahlmann and David Jose Teixeira Rodrigues delivered a comprehensive guide on preventing radial artery occlusion,

Very interesting Edwards Lifesciences Evoque Broadcast yesterday!

'Revolutionising the Treatment of Severe Tricuspid Regurgitation with the EVOQUE System'

Radcliffe Cardiology

NEW #EHRA2024 Late-Breaking Interview 💫Giulio Falasconi, MD discusses findings from the QDOT-by-LAWT trial.

📽️👉 ow.ly/46Qu50Rjgpj

📊Compared to the control group, those in the QDOT-by-LAWT group had a significantly reduced procedure & radiofrequency time.

#EPeeps #CardioEd

NEW #EHRA2024 Late-Breaking Interview 💫Dr Vivek Y. Reddy discusses a first-in-human clinical trial of a novel conformable 'single-shot' #PFA catheter for #PVI .

📽️👉 ow.ly/I35F50Rj6IU

#EPeeps #CardioTwitter

Revolutionising the Treatment of Severe Tricuspid Regurgitation with the EVOQUE System is now LIVE! Tune in here 👉 ow.ly/MgaW50Rj31N

#Cardiology #TTVR #Tricuspid #EVOQUE #TTVI Philipp Lurz

⏰ 1 HOUR TO GO ⏰ Revolutionising the Treatment of Severe #Tricuspid Regurgitation with the #EVOQUE System 🔗 ow.ly/UbWP50Rg0fI

📚Patient selection criteria
📈The latest clinical evidence for #TTVR using the EVOQUE system
🏥Live imaging and procedure analysis using MPR

Don't miss our upcoming broadcast on Postural Orthostatic Tachycardia Syndrome on May 2, featuring a narrative review by experts in the field. Gain insights into this complex syndrome and its management.

Register here 👉 ow.ly/Uoi250RiRUn

#POTS #CardioEd #CardioTwitter

Tune in today to join cardio-oncology experts as they discuss the article “Severe vs Nonsevere Immune Checkpoint Inhibitor-Induced Myocarditis: Contemporary 1-Year Outcomes”➡️ ow.ly/UQ7n50Ri641

🥼Dr Kevin Schesing
🥼Dr Jose Alvarez-Cardona
🥼Prof Dan Lenihan
🥼Prof Joe

NEW #EHRA2024 Late-Breaking Interview 💫Dr Roland Tilz discusses the findings of the Style-AF study on the safety and efficacy of the Perclose ProStyle suture-mediated closure device to manual compression for the treatment of hemostasis after single-shot-device #PVI .

📽️👉

⌛️ 24 HOURS TO GO ⌛️ Revolutionising the Treatment of Severe #Tricuspid Regurgitation with the #EVOQUE System

Tune in tomorrow at 15:00 BST | 16:00 CET🔗 ow.ly/M71250Rg01H

📚 Patient selection criteria
📈 Clinical evidence for TTVR using the EVOQUE system

#TTVR #TTVI

Dr Kevin Schesing, Dr Jose Alvarez-Cardona, Prof Dan Lenihan & Prof Joe Carver discuss the the article “Severe vs Nonsevere Immune Checkpoint Inhibitor-Induced Myocarditis: Contemporary 1-Year Outcomes” ➡️ ow.ly/aulJ50RhWho

#CardioOnc #Cardiology #CardioTwitter International Cardio-Oncology Society

NEW #ACC24 Featured Science Interview 💫Dr Andrew DeFilippis joins us to discuss findings from a subgroup analysis of the MINT Trial.

📽️👉 tinyurl.com/yrncrrz9

📊In pts with type 1 MI and anaemia 👉 a restrictive 🩸transfusion strategy had higher rates of death and MI at 30

It is not everyday that we are given a chance to prove our worth. Striving for best practices sometimes feels it is not valued enough. But a chance to win 3000€ AND to discuss with our peers and experts in the field? Those don't come up so often
radialfirst #CardioTwitter

A great opportunity to share ideas on optimising transradial haemostasis practices

There is still time to register for An Expert Approach to Cardio-Renal Protection in CKD: A Case Based Discussion - Part Two on 18 April at 16:30 BST, 11:30 EDT, chaired by James Burton.

Register for free: radcliffe-group.swoogo.com/cardio-renal-p…

This CME-accredited roundtable offers a

NEW #ACC24 Featured CT Interview 💫Dr Felix Böhm discusses findings from a study investigating fractional flow reserve-guided complete or culprit-only #PCI in pts with #STEMI .

📽️👉 tinyurl.com/dwu4p6n2

📊 #FFR -guided complete non-culprit revascularization did not reduce